S&P 500

5.277,51

0,80%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
PolyPid Ltd (PYPD)
PolyPid Ltd (PYPD) Notícias

PYPD

PolyPid (PYPD)

PolyPid Ltd

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PYPD

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
28/05/2024	17:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PYPD	PolyPid Ltd
06/03/2024	18:28	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PYPD	PolyPid Ltd
06/03/2024	18:05	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:PYPD	PolyPid Ltd
01/03/2024	14:19	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PYPD	PolyPid Ltd
14/02/2024	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PYPD	PolyPid Ltd
01/02/2024	19:26	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:PYPD	PolyPid Ltd
22/01/2024	10:00	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PYPD	PolyPid Ltd
18/10/2023	18:07	AllPennyStocks.com	New Collaboration Could Revolutionize Treatment of Chronic Spinal Cord Injuries	NASDAQ:PYPD	PolyPid Ltd
22/06/2023	08:12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:PYPD	PolyPid Ltd
22/05/2023	10:54	Dow Jones News	FDA Approves PolyPid's Trial Design for D-PLEX	NASDAQ:PYPD	PolyPid Ltd
17/05/2023	12:09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PYPD	PolyPid Ltd
31/03/2023	16:55	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:PYPD	PolyPid Ltd
31/03/2023	07:05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PYPD	PolyPid Ltd
24/01/2023	12:24	Dow Jones News	PolyPid Shares Rise 28% After Positive FDA News for D-PLEX	NASDAQ:PYPD	PolyPid Ltd
12/12/2022	11:50	TipRanks	Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and PolyPid (PYPD)	NASDAQ:PYPD	PolyPid Ltd
09/11/2022	16:45	TipRanks	PolyPid (PYPD) Gets a Buy from JMP Securities	NASDAQ:PYPD	PolyPid Ltd
28/09/2022	14:35	TipRanks	JMP Securities Sticks to Its Buy Rating for PolyPid (PYPD)	NASDAQ:PYPD	PolyPid Ltd
02/09/2022	13:15	TipRanks	JMP Securities Remains a Buy on PolyPid (PYPD)	NASDAQ:PYPD	PolyPid Ltd
11/08/2022	12:06	TipRanks	Analysts’ Top Healthcare Picks: PolyPid (PYPD), Nuvalent (NUVL)	NASDAQ:PYPD	PolyPid Ltd
10/08/2022	12:15	TipRanks	JMP Securities Keeps Their Buy Rating on PolyPid (PYPD)	NASDAQ:PYPD	PolyPid Ltd
24/06/2022	10:29	TipRanks	BMO Capital Thinks PolyPid’s Stock is Going to Recover	NASDAQ:PYPD	PolyPid Ltd
23/06/2022	15:25	TipRanks	JMP Securities Thinks PolyPid’s Stock is Going to Recover	NASDAQ:PYPD	PolyPid Ltd
23/05/2022	12:25	TipRanks	Analysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Nektar Therapeutics (NKTR)	NASDAQ:PYPD	PolyPid Ltd
12/05/2022	09:51	TipRanks	BMO Capital Keeps a Buy Rating on PolyPid (PYPD)	NASDAQ:PYPD	PolyPid Ltd
11/05/2022	13:49	TipRanks	Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agenus (AGEN), Intercept Pharma (ICPT) and PolyPid (PYPD)	NASDAQ:PYPD	PolyPid Ltd
24/02/2022	15:18	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PYPD	PolyPid Ltd
04/01/2022	03:53	TipRanks	Polypid Names New CEO; Shares Jump 6.3%	NASDAQ:PYPD	PolyPid Ltd
16/12/2021	02:25	TipRanks	PolyPid (PYPD) Gets a Buy Rating from JMP Securities	NASDAQ:PYPD	PolyPid Ltd
30/08/2021	17:17	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:PYPD	PolyPid Ltd
12/07/2021	07:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PYPD	PolyPid Ltd